retatrutide 2024 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric ESC 2024: Retatrutide improves lipid

Growing up in Montreal, Canada, Drucker did his undergraduate studies at the University of Ottawa and then completed his internal medicine and endocrinology residencies at the University of Toronto, followed by postgraduate endocrinology training at Johns Hopkins Hospital

Oxyntomodulin (OXM) is a gut peptide produced by the colonic EECs that acts via GLP-1Rs and glucagon receptors 205,206 to reduce body weight 207,208 and improve glucose metabolism 209,210

If you have known diabetic retinopathy, visual symptoms, or overdue retinal screening, you should arrange timely ophthalmic follow-up

While insurers frequently cover these drugs for diabetes, weight-loss-only prescriptions may face denials

Van Bloemendaal et al., 2014)

R.HermanJ